Interferon treatment of human neoplasia.
D000818:Animals; D000906:Antibodies; D001932:Brain Neoplasms / Q000628:therapy; D002292:Carcinoma, Renal Cell / Q000628:therapy; D002455:Cell Division / Q000187:drug effects; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007369:Interferon Inducers; D007372:Interferons / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D007680:Kidney Neoplasms / Q000628:therapy; D007694:Killer Cells, Natural / Q000276:immunology; D007700:Kinetics; D007938:Leukemia / Q000628:therapy; D008175:Lung Neoplasms / Q000628:therapy; D008223:Lymphoma / Q000628:therapy; D008545:Melanoma / Q000628:therapy; D051379:Mice; D008819:Mice, Nude; D009101:Multiple Myeloma / Q000628:therapy; D009369:Neoplasms / Q000628:therapy*; D009374:Neoplasms, Experimental / Q000628:therapy; D012516:Osteosarcoma / Q000628:therapy; D012514:Sarcoma, Kaposi / Q000628:therapy; D001749:Urinary Bladder Neoplasms / Q000628:therapy
D000906:Antibodies; D007369:Interferon Inducers; D007372:Interferons